Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)

NCT: NCT07754318 · NOT_YET_RECRUITING

NCT IDNCT07754318
StatusNOT_YET_RECRUITING
Start Date2026-10
Completion2030-08
SponsorMedtronic Cardiovascular (INDUSTRY)
First posted
Last updated

Brief Summary

To evaluate the safety and effectiveness of the Heli-FX EndoAnchor system in AAA subjects who without augmented radial fixation and/or sealing due to an endoleak or migration are at high risk for aneurysm-related complications or who are at high risk of migration or endoleak complications post-procedure, and to support product registration of Heli-FX EndoAnchor system with the National Medical Product Administration (NMPA) in China.

Frequently Asked Questions

What is Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)?

Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA) is a clinical trial registered under NCT07754318. Current status: NOT_YET_RECRUITING.

What is the status of NCT07754318?

The current status of NCT07754318 (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)) is: NOT_YET_RECRUITING.

When did Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA) start?

Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA) started on 2026-10.

Related Devices

K182957Heli-FX EndoAnchor SystemMedtronic Vascular, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑